News and Announcements
Oncosil Medical Group (ASX:OSL) Annual Update 2015; Shares Up Over 182%
- Published January 05, 2016 2:42PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
2015 Highlights:
- Share price up 182.35%
- Completed the granted Fast Track review by the European regulator Conformité Européenne
- International life sciences research group, Van Leeuwenhoeck Institute, initiated an analyst research coverage on the Company
- Multiple new Board Appointments
OncoSil™ is a patent protected proprietary medical device (class III) that creates a localised stream of beta radiation. The product is created by melting up to 5% phosphorous in liquid silicon in a furnace which is then shattered into small particles using sterile water. The resulting radioactive phosphorous (P32) produces radioactive beta particles that can be emitted for up to three months.
Patients with unresectable pancreatic cancer have few treatment options. The current standard of care is to provide intravenous chemotherapy, and in some cases external beam radiation. The OncoSil™ is intended to complement existing standard of care chemotherapy.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
